經過新冠疫情，我們發現世界還沒準備好面對這個本該能被預見的大流行。但我們忽略了去充分投資全球衛生系統的發展及維護
然而，我們忽視了對發展和維持全球衛生系統復原力的充分投資。因此，COVID-19 大流行應該給全球領導人敲響警鐘，其重要性和緊迫性與十多年前的全球金融危機和當今日益惡化的氣候緊急情況一樣重要。
As global leaders emerge from the COVID-19 pandemic, we must seize the opportunity to learn the lessons from this crisis, making it a catalyst for serious reforms – both for improving the health resilience of economies and for looking more deeply at the issue of healthier alongside cleaner growth.
The Reform for Resilience Commission (R4RX) was created to shape new models, metrics, and practical policy reforms to help leaders in the public and private sectors deliver the changes needed for healthier growth.
The Asia Pacific was successful in preserving public health and economic prosperity in 2020, piquing interest in how the region tracked, contained, and controlled the spread of COVID-19. However, the pandemic has posed systemic challenges to these societies that will change how public health, business, and environmental stewardship are conducted.
The Asia-Pacific Hub of the Reform for Resilience Commission housed at CAPRI collaborates with the Secretariat, the Americas Hub at the Harvard T.H. Chan School of Public Health, and international partners to spearhead the Resilience Commission’s research and networking.
At GHS2022 in Singapore, CAPRI joined Reform for Resilience’s co-chairs and hubs for their first in-person meeting, using the sidelines of the conference to align on strategy, research priorities, and convening.
We participated in the Healthcare System Resilience Summit at World Expo 2020 in Dubai. The CAPRI leadership together with experts and leaders worldwide discussed learnings from the pandemic and key innovations for recovery and resilience of healthcare systems.
With the arrival of the O
亞堅會與維吉尼亞大學米勒中心、哈佛大學陳曾熙公共衛生學院、歐洲大學學院跨國治理學院，以及劍橋大學公共衛生研究中心合作舉辦線上研討會，邀集 14 位專家共同探討疫苗研發、分配與接種接受度的三重挑戰。本次活動亦為亞堅會《疫苗與三重挑戰》報告的研究發表會，並強調透過創新政策與私部門解方來強化全球健康體系的韌性。
本報告針對全球受眾，主軸探討疫苗作為亞太地區表現韌性的關鍵。產於一個快速多變的疫情時代，此報告包含區域專家的訪談以及2021下半年所新增的研究，旨在點出影響疫苗分配公平性與接種過程的因素，以及這些因素將如何形塑未來亞太地區的韌性表現。
Building on insights from
Although vaccine developm
